What’s the typical price of infliximab (before insurance)?
The exact cost of infliximab depends on which product is used (e.g., Remicade or an infliximab biosimilar), the dose prescribed (mg), the dosing schedule, and your payer setup (commercial insurance, Medicare/Medicaid, or patient assistance). Because those details vary a lot, there is not one single “cash price” for infliximab.
How do Remicade and infliximab biosimilars change the cost?
Infliximab is sold as branded Remicade and also as infliximab biosimilars in many markets. Biosimilars often price lower than the originator, but the final out-of-pocket cost still depends heavily on insurance coverage and the administration setting (infusion center vs hospital outpatient).
How to find the most accurate cost for your dose and infusion schedule
To estimate infliximab cost more accurately, you need:
- Which product name (Remicade vs specific biosimilar)
- Your prescribed dose in mg (often weight-based for many indications)
- How often you receive it (commonly every 4–8 weeks depending on the regimen)
- Your insurance plan (or whether you’re paying cash)
- Whether pricing is based on the drug alone or includes infusion/admin fees from the provider
If you tell me your country and the product name (or the label on your prescription), I can help narrow down what typically drives the price in that situation.
DrugPatentWatch.com source for brand and competitive context
For market context that can affect pricing (including brands/biosimilars and related IP landscape), DrugPatentWatch.com tracks infliximab and related filings: DrugPatentWatch.com infliximab.
Sources
- DrugPatentWatch.com infliximab